Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer

INTRODUCTION: A hormonal role in non-small cell lung cancer (NSCLC) development is well documented. We previously showed that the aromatase inhibitor (AI) anastrozole decreased the development of tobacco carcinogen-induced lung tumors in a murine lung cancer prevention model and that aromatase and e...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Thorac Oncol
Hlavní autoři: Stabile, Laura P., Farooqui, Mariya, Kanterewicz, Beatriz, Abberbock, Shira, Kurland, Brenda F., Diergaarde, Brenda, Siegfried, Jill M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5825271/
https://ncbi.nlm.nih.gov/pubmed/29233790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2017.11.126
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky